Assaying narcotic-antagonist drugs for analgesic activity in rhesus monkeys.
D000700:Analgesics / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D001952:Bridged-Ring Compounds / Q000037:antagonists & inhibitors / Q000494:pharmacology; D003496:Cyclazocine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004597:Electroshock; D000882:Haplorhini; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D008251:Macaca; D008297:Male; D009020:Morphine / Q000494:pharmacology; D009269:Nalorphine / Q000494:pharmacology; D009281:Naphthalenes / Q000037:antagonists & inhibitors / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology*; D010423:Pentazocine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D011680:Pupil / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D013997:Time Factors
D000700:Analgesics; D001952:Bridged-Ring Compounds; D006993:Hypnotics and Sedatives; D009281:Naphthalenes; D009292:Narcotic Antagonists; D009020:Morphine; D003496:Cyclazocine; D010423:Pentazocine; D009269:Nalorphine